Quest Diagnostics (BSP:Q1UE34) Additional Paid-In Capital : R$11,414 Mil(As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Quest Diagnostics Additional Paid-In Capital?

Quest Diagnostics's quarterly additional paid-in capital declined from Sep. 2023 (R$11,369 Mil) to Dec. 2023 (R$11,368 Mil) but then increased from Dec. 2023 (R$11,368 Mil) to Mar. 2024 (R$11,414 Mil).

Quest Diagnostics's annual additional paid-in capital declined from Dec. 2021 (R$12,780 Mil) to Dec. 2022 (R$12,038 Mil) and declined from Dec. 2022 (R$12,038 Mil) to Dec. 2023 (R$11,368 Mil).

Quest Diagnostics Additional Paid-In Capital Historical Data

The historical data trend for Quest Diagnostics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Additional Paid-In Capital Chart

Quest Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

11,172.45

14,616.09

12,780.07

12,038.19

11,367.54

Quest Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															11,802.69	11,085.85	11,368.89	11,367.54	11,413.70

Quest Diagnostics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Quest Diagnostics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest Diagnostics (BSP:Q1UE34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (BSP:Q1UE34) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

DGX:USA QDI:Germany

Address

500 Plaza Drive, Secaucus, NJ, USA, 07094

Website

https://www.questdiagnostics.com

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (BSP:Q1UE34) Headlines

No Headlines